As an immediate follow-up to last week’s release of the FDA’s Biosimilars Action Plan, the Agency ..
In May, the Trump Administration announced its Blueprint to Lower Drug Prices and HHS Secretary Azar ..
On July 18, 2018, after months of alluding to the various aspects of an upcoming “Biosimilar Action ..
A lot has happened since we last addressed new biosimilar developments in January 2018. In the intervening ..
On Friday, after weeks of delay, the President finally delivered his Drug Pricing Speech and released ..